Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anthology Diagnostics is a U.S.-based molecular diagnostics laboratory focused on precision oncology testing. The company was launched through a collaboration between Hackensack Meridian Health and Genomic Testing Cooperative to provide comprehensive genomic profiling for cancer patients, physicians, hospitals, and regional laboratories. Its offerings center on next-generation sequencing of both DNA and RNA for solid tumors and hematologic malignancies, including liquid biopsy and other molecular profiling services used to support diagnosis, subclassification, treatment selection, and clinical trial matching. Anthology Diagnostics appears to operate as a clinical service laboratory rather than a therapeutic drug developer, with commercial diagnostic services already in use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anthology Diagnostics.